Pursuant to Regulation 39(3) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 as amended, this is to inform you that Big share Services Pvt. Ltd., the Registrar and Share Transfer Agent of the Company has received information regarding loss of share certificate along with request for issuance of duplicate share certificate, details of which are given below:
Folio No.
Certificate
No of
Distinctive No.
Name of the shareholder
JH1
No.
shares
From
To
KLC1812
904582
100
6057051
6057150
CHIRAG M GOSAI
-
This is for your information and record.
Regards,
For Kopran Limited
SODHANI SUNIL RADHEYSHYAM
Digitally signed by SODHANI SUNIL RADHEYSHYAM Date: 2022.12.27 16:01:07 +05'30'
Sunil Sodhani
Company Secretary & Compliance Officer
Membership No. FCS 3897
KOPRAN LTD.: Parijat House, 1076, Dr. E. Moses Road, Worli, Mumbai - 400 018. P. B. No. 9917, Tel.: (022) 4366 1111
Kopran Ltd. published this content on 27 December 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 December 2022 11:19:37 UTC.
Kopran Limited is an India-based integrated pharmaceutical company. The Company is primarily engaged in the business of manufacturing of formulation (finished dosage form) and active pharmaceutical ingredients (APIs). Its formulations product categories include penicillin-based finished oral dosage forms and non-penicillin-based finished oral dosage forms. The Company's penicillin-based finished oral dosage forms include anti-infective, amoxycillin, ampicillin, cloxacillin and amoxy clauv. Its non-penicillin-based finished oral dosage forms include macrolides, anti-hypertensive, cardiovascular, anti-helmentics, antihistamine, anti-diabetic, pain management and gastroenterology. It provides ingredients in a wide range of pharmaceutical products, such as capsules, injectables and tablets, among others. The Company's APIs products include anti-hypertensive, macrolides, neuromodulator, urological, anti-infective/anti-acne, sterile carbapenems and sterile cephalosporins.